DYMISTA (azelastine hydrochloride; fluticasone propionate) Mylan speciality lp Patent: 8,163,723 Expiration: Feb 29, 2024 See More … For more information […]
Drug Patent Expirations for the Week of February 25, 2024 Read Post »
Annual Drug Patent Expirations for GRALISE Gralise is a drug marketed by Almatica and is included in one NDA. It
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Annual Drug Patent Expirations for ANJESO Anjeso is a drug marketed by Baudax and is included in one NDA. There
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA.
New patent expiration for Boehringer Ingelheim drug OFEV Read Post »
Annual Drug Patent Expirations for ZOLINZA Zolinza is a drug marketed by Msd Sub Merck and is included in one
AURYXIA (ferric citrate) Keryx biopharms Patent: 9,050,316 Expiration: Feb 18, 2024 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of February 18, 2024 Read Post »
Annual Drug Patent Expirations for EXSERVAN Exservan is a drug marketed by Aquestive and is included in one NDA. It
New patent expiration for Aquestive drug EXSERVAN Read Post »
Get fresh news and insights, drug patent expirations & more…
